Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, ... Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts. Mehr anzeigen
Verrica Pharmaceuticals Inc. Investor Alert (NASDAQ: VRCA): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors for Possible...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.1306 | -8.3152935184 | 1.5706 | 1.7382 | 1.4 | 350816 | 1.55420547 | CS |
| 4 | 0.12 | 9.09090909091 | 1.32 | 1.7382 | 1.22 | 404632 | 1.45684612 | CS |
| 12 | -3.56 | -71.2 | 5 | 5.82 | 1.0404 | 1029988 | 2.10752986 | CS |
| 26 | -5.81 | -80.1379310345 | 7.25 | 11.41 | 1.0404 | 610125 | 3.26782276 | CS |
| 52 | -2.58 | -64.1791044776 | 4.02 | 11.41 | 1.0404 | 625950 | 4.6465746 | CS |
| 156 | -11.46 | -88.8372093023 | 12.9 | 13.535 | 1.0404 | 350167 | 4.65279238 | CS |
| 260 | -12.91 | -89.9651567944 | 14.35 | 18.67 | 1.0404 | 250126 | 5.74530333 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
